Truist Securities Maintains Buy on Affimed, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Srikripa Devarakonda has maintained a 'Buy' rating on Affimed (NASDAQ:AFMD), but lowered the price target from $8 to $6.

August 11, 2023 | 2:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Affimed's price target has been lowered from $8 to $6 by Truist Securities, though the 'Buy' rating is maintained.
The lowering of the price target by Truist Securities could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the stock, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100